Patent · US Active

Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

US9174982B2 · kind B2 · utility

15Cited by

41References

7Claims

0Family size

Assignees

Abb Vie Inc. · US
Genentech, Inc. · US
THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH · AU

Inventors

Milan Bruncko · Libertyville, US
Hong Ding · Gurnee, US
George A. Doherty · Libertyville, US
Steven W. Elmore · Northbrook, US
Lisa A. Hasvold · Grayslake, US
Laura Hexamer · Grayslake, US
Aaron R. Kunzer · Arlington Heights, US
Xiaohong Song · Beijing, CN
Andrew J. Souers · Libertyville, US
Gerard M. Sullivan · Round Lake Beach, US
Zhi-Fu Tao · Vernon Hills, US
Gary T. Wang · Libertyville, US
Le Wang · Xi'an, CN
Xilu Wang · Grayslake, US
Michael D. Wendt · Vernon Hills, US
Robert A. Mantei · Franklin, US
Todd M. Hansen · Grayslake, US

Key dates

Filing date	Sep 26, 2013
Grant date	Nov 3, 2015
Priority date	—
Expiry date	Sep 26, 2033

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.